Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control
Article in Frontiers in Immunology (September 2023)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (September 2023)
Article in Frontiers in Neurology (May 2023)
Article in Acta Neuropathologica (June 2022)